Comparative Analysis of Decitabine Intensified BUCY2 and BUCY2 Conditioning Regimen for High-Risk MDS Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Researchers retrospectively evaluated 93 consecutive high-risk myelodysplastic syndrome patients undergoing allo-hematopoietic stem cell transplantation in our institution, comparing discrepancies in clinical characteristics and outcomes between cases using Dec-intensified BUCY2 and traditional BUCY2 regimen.